The analysis identified lymph node metastasis, invasion of retroperitoneal tissue, and hypermethylation of RUNX3 gene as the variables for independently predicting overall survival (Table 3). The gene discussed is RUNX3; the disease is metastatic malignant neoplasm in the lymph nodes.